IMMUNOREGULATORISCHER IMPFSTOFF

European patent · EP2872169 · In force

Register entry

Publication number
EP2872169
Application number
EP13732967
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jul 2, 2013
Published
May 20, 2015
Granted
Sep 1, 2021
Protection ends at the latest
Jul 1, 2033
Next annual fee due
Jul 31, 2027
IPC classes
A61K 39/00 (2006.01)
A61K 39/36 (2006.01)
Priority
EP 12176348 13.07.2012
EP 13158410 08.03.2013
EP 13168578 21.05.2013
PCT application
PCT/EP2013/063959 02.07.2013
PCT publication
WO2014/009209 16.01.2014
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.07.2026 → 31.07.2027

    Published in Swissreg on 01.08.2026

  2. Aug 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.07.2025 → 31.07.2026

    Published in Swissreg on 01.08.2025

  3. Aug 1, 2024

    Change

    Published in Swissreg on 01.08.2024

  4. Aug 1, 2023

    Change

    Published in Swissreg on 01.08.2023

  5. Aug 1, 2022

    Change

    Published in Swissreg on 01.08.2022

  6. Jul 13, 2022

    Change

    Published in Swissreg on 13.07.2022

  7. Dec 30, 2021

    Agent entered

    Representative
    Murgitroyd & Company, 4, Rue du Commerce, 1204 Genève

    Published in Swissreg on 30.12.2021

  8. Sep 1, 2021

    Granted

    Published in Swissreg on 01.09.2021

Parties

Holder

S-TARget therapeutics GmbH

Divischgasse 4, 1210 Vienna, AT

Agent

Murgitroyd & Company

1204 Genève

Inventor

MUDDE, Geert

A-2384 Breitenfurt, AT

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.